BackCoherent Overview
Coherent Corp

Coherent Target Price

See Coherent's analyst price targets ($390) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$306.43

Average Target Price

$394.1028.6% upside

10 analysts in the last 4 months

High: $455 | Low: $230

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-13Stifel NicolausRuben Roy$42037.1% upsideOpen
2026-08-13Raymond James$44846.2% upsideOpen
2026-08-13NeedhamRyan Koontz$42037.1% upsideOpen
2026-08-13Jefferies$42037.1% upsideOpen
2026-07-02Raymond James$43542% upsideOpen
2026-05-07Morgan StanleyMeta Marshall$3307.7% upsideOpen
2026-05-07Northland Securities$23024.9% downsideOpen
2026-05-07Raymond James$37121.1% upsideOpen
2026-05-05Stifel Nicolaus$41234.5% upsideOpen
2026-05-01Redburn PartnersMike Harrison$45548.5% upsideOpen
2026-04-20Morgan Stanley$2905.4% downsideOpen
2026-02-23Morgan StanleyMeta Marshall$25018.4% downsideOpen
2026-02-05Northland SecuritiesTim Savageaux$17044.5% downsideOpen
2026-02-05Stifel Nicolaus$23523.3% downsideOpen
2026-02-05BarclaysTom O'Malley$23523.3% downsideOpen
2026-01-30Morgan StanleyMeta Marshall$19038% downsideOpen
2026-01-22Stifel NicolausRuben Roy$22028.2% downsideOpen
2026-01-22SusquehannaChristopher Rolland$23523.3% downsideOpen
2026-01-15BarclaysTom O'Malley$21529.8% downsideOpen
2025-12-17Morgan StanleyMeta Marshall$18041.3% downsideOpen
2025-12-05Raymond JamesSimon Leopold$21031.5% downsideOpen
2025-11-06Needham$19038% downsideOpen
2025-11-06Susquehanna$16047.8% downsideOpen
2025-11-06Morgan StanleyMeta Marshall$15051% downsideOpen
2025-10-22SusquehannaChristopher Rolland$15051% downsideOpen
2025-10-20BarclaysTom O'Malley$13555.9% downsideOpen
2025-10-10Morgan Stanley$12060.8% downsideOpen
2025-08-14BarclaysTom O'Malley$11064.1% downsideOpen
2025-08-04Morgan Stanley$9768.3% downsideOpen
2025-06-02Northland SecuritiesTim Savageaux$8572.3% downsideOpen
2025-03-24Raymond JamesStrong Buy$9170.3% downsideOpen
2024-11-07Loop Capital MarketsAnanda Baruah$12060.8% downsideOpen
2024-10-22Rosenblatt SecuritiesMike Genovese$10565.7% downsideOpen
2024-10-18B.Riley FinancialDave Kang$8671.9% downsideOpen
2024-10-14NeedhamJames Ricchiuti$12060.8% downsideOpen
2024-10-04Bank of America SecuritiesVivek Arya$10864.8% downsideOpen
2024-10-01SusquehannaChristopher Rolland$12060.8% downsideOpen
2024-08-16Craig-HallumRichard Shannon$8572.3% downsideOpen
2024-08-16NeedhamJames Ricchiuti$8472.6% downsideOpen
2024-08-16Rosenblatt SecuritiesMike Genovese$8472.6% downsideOpen
2024-08-15NeedhamAlex Henderson$7077.2% downsideOpen
2024-08-12Bank of America SecuritiesVivek Arya$7575.5% downsideOpen
2024-04-01B.Riley FinancialDave Kang$7774.9% downsideOpen
2024-04-01NeedhamJames Ricchiuti$7276.5% downsideOpen
2024-01-16BarclaysTom O'Malley$6080.4% downsideOpen
2023-12-15NeedhamJim Ricchiuti$5283% downsideOpen
2023-10-11NeedhamJames Ricchiuti$5083.7% downsideOpen
2023-06-20NeedhamJim Ricchiuti$6479.1% downsideOpen
2022-12-13Morgan Stanley$4585.3% downsideOpen
2022-11-28Deutsche Bank$5083.7% downsideOpen

Coherent (COHR) FAQ

Coherent posts a target price of $390. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

A target price of $390 for COHR means covering analysts, on average, see the stock 28.6% upside of $306.43 over about 12 months. Dig into who set the high and low targets and how recently they updated — freshness matters as much as the average itself.

Context for COHR's target price usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Coherent's other metric pages and overview cover the third.

Judging Coherent against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in target price easier to interpret. Start with $390 here, then scan peer and history charts to see if the gap is persistent.